+987.9%
MRNA vs VEEV
+6.7%
+981.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VEEV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +2.4% | +10.7% | +11.8% |
| 7D | +20.6% | -2.3% | +22.9% | +22.0% |
| 30D | +27.1% | +9.6% | +17.6% | +21.4% |
| 3M | +353.4% | +46.6% | +306.8% | +287.4% |
| 6M | +446.3% | +82.5% | +363.8% | +340.6% |
| YTD | +776.2% | +39.2% | +737.0% | +668.3% |
| 1Y | +987.9% | +5.8% | +982.1% | +799.7% |
| All | +987.9% | +6.7% | +981.2% | +799.7% |
Cumulative growth
Daily Returns
Daily percentage return beside VEEV.
Daily Out/Under-Performance
Portfolio return minus VEEV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VEEV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VEEV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling